School of Medicine
Showing 401-450 of 1,194 Results
-
Scott S. Hall, Ph.D
Professor of Psychiatry and Behavioral Sciences (Child and Adolescent Psychiatry and Child Development)
Current Research and Scholarly InterestsMy primary area of scholarly and clinical interest is the pathogenesis of problem behaviors shown by individuals diagnosed with intellectual and developmental disabilities (IDD), particularly those with neurogenetic forms of IDD, such as fragile X syndrome, Cornelia de Lange syndrome and Prader-Willi syndrome. My work aims to both advance understanding of these disorders and to identify effective new treatment approaches for pediatric and adult patient populations by state-of-the-art methodologies, such as brain imaging, eye tracking and functional analysis to determine how environmental and biological factors affect the development of aberrant behaviors in these syndromes. The end goal of my research is to create patient-specific methods for treating the symptoms of these disorders.
-
Haijing Wu Hallenbeck
Instructor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psych/Public Mental Health & Population SciencesBioHaijing Hallenbeck, PhD, is a research investigator at the National Center for PTSD Dissemination & Training Division at VA Palo Alto Health Care System. She is also an Instructor (Affiliated) in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She received her PhD in Clinical Psychology from Washington University in St. Louis and completed her predoctoral clinical internship and postdoctoral research fellowship at VA Palo Alto Health Care System. Funded by VA Career Development Awards, Dr. Hallenbeck's research focuses on PTSD and depression and their impact on psychosocial functioning. She studies how to leverage digital health technology (e.g., mobile apps) and analytic tools (e.g., network analysis) to provide timely and personalized assessments and interventions.
Email: haijing.hallenbeck@stanford.edu -
Joachim Hallmayer
Professor of Psychiatry and Behavioral Sciences (Child and Adolescent Psychiatry and Child Development)
On Partial Leave from 09/01/2024 To 08/31/2026Current Research and Scholarly InterestsPrincipal Investigator
Infrastructure to facilitate discovery of autism genes
The purpose of this project is to facilitate the discovery of the genes that contribute autism by maintaining an infrastructure which research groups studying the genetics of autism can work collaboratively. This will be
accomplished through workshops, a Virtual Private Network, and access to a database that includes phenotype and genotype data from all participating groups.
Principal Investigator
A California Population-Based Twin Study of Autism
This will address several fundamental questions: (1) What is the heritability of autism (2) What is the contribution of genetic factors to variation in symptom dimensions? (3) Is there a continuum between the quantitative neurocognitive traits and clinical disorder? (4) What proportion of the variance in the neurocognitive traits is accounted for by genetic and non-genetic factors?
Co-Investigator
Center for Integrating Ethics in Genetics Research(Cho)
The goal of this project is to serve as a center of excellence in neurogenetics research, to develop a national model for bench, to bedside research ethics consultation, and to provide training opportunity in biomedical ethics.
Co-Investigator
Gene, Brain and Behavior in Turner Syndrome(Reiss)
The primary objective of this project is to use advanced, multi-modal magnetic resonance imaging (MRI) techniques, analyses of X chromosome parent-of-origin and cognitive-behavioral assessment to elucidate the effects of monosomy and X-linked imprinting on neurodevelopment and neural function in a large cohort of young girls with Turner syndrome, pre-estrogen replacement.
Project Director
Project F: Genomic Analysis in narcolepsy cataplexy
The goal of the project is to locate genes outside the HLA region that influence susceptibility to narcolepsy. In order to localize these genes we will carry out a linkage and association study in the most extensive world-wide collection of DNAs from well-characterized patients with narcolepsy and their families. -
Bonnie Halpern-Felsher
Marron and Mary Elizabeth Kendrick Professor of Pediatrics and Professor, by courtesy, of Epidemiology and Population Health and of Psychiatry and Behavioral Sciences (Child and Adolescent Psychiatry)
Current Research and Scholarly InterestsResearch focuses on developmental, cognitive and psychosocial factors involved in adolescents’ and young adults’ health-related decision-making, perceptions of risk and vulnerability, health communication and risk behavior. My research has focused on understanding and reducing health risk behaviors such as tobacco use, alcohol and marijuana use, risky driving, and risky sexual behavior.
-
Mindy Hantke
Public Rel Offcr 3, Psychiatry and Behavioral Sciences
Current Role at StanfordWeb & Communications Administration
-
Antonio Hardan, M.D.
Professor of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe neurobiology of autism
Neuroimaging in individuals with autism
Psychopharmacological treatment of children and adults with autism and/or developmental disorders
The neurobiology and innovative interventions of several neurogenic disorders including DiGeorge Syndrome (Velocardiofacial syndrome; 22q11.2 mutations), PTEN mutations, and Phelan McDermid Syndrome (22q13 mutations). -
Kate Hardy
Clinical Professor, Psychiatry and Behavioral Sciences
BioKate Hardy is a California Licensed Psychologist who has specialized in working with individuals with psychosis for over 20 years in both research and clinical settings. Dr. Hardy received her doctorate in clinical psychology from the University of Liverpool, United Kingdom. She has worked in specialist early psychosis services in both the UK and the US, including UCSF’s Prodrome Assessment Research and Treatment (PART) program, where she completed her post-doctoral fellowship, and as Clinical Director for the Prevention and Recovery from Early Psychosis (PREP) program. Dr. Hardy is the co-director for the INSPIRE clinic at the Department of Psychiatry and Behavioral Health, Stanford University and has significant experience in providing CBTp to individuals with early psychosis, and those at risk of developing psychosis, in both individual and group settings and integration of this clinical intervention to broader systems and staff teams. Dr. Hardy is also involved in the implementation of national strategies to increase dissemination of early psychosis models with the aim of bringing these cutting edge treatments to a broader population and is the co-editor of the book Intervening Early: A team approach.
Dr. Hardy is also the director of INSPIRE training and within this role has led multiple trainings and workshops in CBTp to a wide variety of audiences including community clinicians, psychiatrists, and families, and provides ongoing supervision and consultation in this approach. INSPIRE training offers training in evidence based interventions for psychosis to providers across diverse settings. In 2024 Dr. Hardy became president elect for IEPA: Intervening Early in Mental Health. -
Earth Hasassri, MD
Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Earth Hasassri is an Adjunct Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences, Division of Child and Adolescent Psychiatry and Child Development at Stanford University School of Medicine. He has a private practice in Menlo Park and teaches medical students, residents, and fellows at Stanford University School of Medicine. In his private practice, he specializes in seeing children and adults with complex psychiatric conditions such as ADHD, autism spectrum disorders, functional neurological disorders, those with epilepsy, and other neuropsychiatric conditions. His interests are caring for individuals who suffer from medical conditions at the interface of medicine and psychiatry.
Prior to medical school, Dr. Hasassri graduated with dual bachelor's degrees in neurophysiology and psychology at the University of California San Diego, where he performed research on sleep medicine. He earned his medical degree from the Mayo Clinic Alix School of Medicine where he did research in clinical epidemiology. Dr. Hasassri completed his residency in general psychiatry at the University of California San Francisco Langley Porter Psychiatric Hospitals & Clinics, during which he was awarded an Area of Distinction in Clinical Neuroscience for his work in applying neuroscientific principles in his clinical work in those with brain cancer, dementia, neurodevelopmental disorders, and other neuropsychiatric conditions. Dr. Hasassri is dual board certified in adult psychiatry and in child and adolescent psychiatry through the American Board of Psychiatry and Neurology, a member Board of the American Board of Medical Specialties. -
Nancy A. Haug
Adjunct Clinical Professor, Psychiatry and Behavioral Sciences
BioNancy A. Haug, PhD is Adjunct Clinical Professor and Addiction Medicine fellowship program faculty in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She currently leads didactics and a journal club for Addiction Medicine fellows, and teaches a postdoctoral seminar on ethics and legal issues for the Clinical Psychology Fellowship Program. Dr. Haug's primary academic affiliation is Professor of Psychology at Palo Alto University, where she teaches, advises and supervises doctoral students in the PAU-Stanford PsyD Consortium. Dr. Haug previously served as faculty and attending psychologist in the Department of Psychiatry at the University of California San Francisco, and taught in the University of California, Berkeley Alcohol & Drug Studies program. She obtained her PhD in Clinical Psychology and Behavioral Medicine at the University of Maryland, Baltimore County and a Master's degree in Counseling Psychology at Loyola University, Maryland. She completed a clinical internship and postdoctoral fellowship at University of California, San Francisco and San Francisco General Hospital in public service and minority mental health.
Dr. Haug chairs the American Psychological Association (APA) Ethics Committee and formerly served on the California Psychological Association Ethics Committee. She is a Fellow, Member-at-Large for Practice, and President- Elect of the Society of Addiction Psychology (Division 50). Dr. Haug is on the editorial board of the Journal of Psychoactive Drugs and the Journal of Addictive Diseases. She was funded by SAMHSA for a practitioner-education initiative to expand training for evidence-based addiction treatment. Dr. Haug leads the Harm Reduction and Addiction Treatment Laboratory at PAU with current research studies on the implementation of evidence-based practices in addiction treatment, harm reduction for substance use, cannabis vaping and psychedelic-assisted psychotherapy.
Dr. Haug has been licensed as a psychologist in California since 2004, is board certified in addiction psychology by American Board of Professional Psychology, and has an independent practice in Los Gatos, CA. She has clinical expertise in treating substance misuse and eating disorders using motivational interviewing, cognitive-behavioral and mindfulness-based therapies including Acceptance and Commitment Therapy. Dr. Haug is a Stanford WellConnect referral for fellows, residents and faculty in her clinical practice. She completed the Stanford YogaX 200-Hour Yoga Teacher Training Program with healthcare setting emphasis. -
Chris Hayward
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)
Current Research and Scholarly InterestsDr. Hayward's research has focused on risk factors for the onset of adolescent internalizing disorders in adolescent girls and the role of early puberty specifically.
-
Alesha Heath
Basic Life Research Scientist, Psych/Public Mental Health & Population Sciences
BioDr. Alesha Heath is a Postdoctoral Scholar at Psychiatry and Behavioral Sciences at Stanford School of Medicine and the MIRECC the VA Palo Alto. She earned her PhD from the University of Western Australia and Sorbonne University.
Dr. Heath's research has been primarily focused on the mechanisms and applications of brain stimulation therapies, in particular repetitive transcranial magnetic stimulation. Her research involves both basic and clinical components with the aim of improving the efficacy of these therapies for the treatment of disorders such as depression and Alzheimer's disease. -
Katherine (Heflin) Hefcart
Affiliate, Department Funds
Resident in Psychiatry and Behavioral SciencesBioAdult Psychiatry Resident, focusing on Community/Public Psychiatry, LGBTQ+ competent care, integrative mental health, and reproductive psychiatry. Attended Stanford undergraduate ('11), Harvard T.H. Chan School of Public Health ('15), Dartmouth Geisel Medical School ('23).
-
Nuriya Ruth Hefron
Professional - NX, Psych/Public Mental Health & Population Sciences
Current Role at StanfordProgram Manager INSPIRE 360
Expansion of Early Psychosis Care Program -
John P. Hegarty II
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioI am a neuroscientist and Principal Investigator of the Stanford Clinical Neuroscience (CNS) Lab in the Department of Psychiatry and Behavioral Sciences as well as Director of Neuroimaging for the Autism and Developmental Disorders Research Program at Stanford. My innovative research studies clinical aspects of cognitive and behavioral neuroscience, with a special focus on examining the neural circuitry associated with important brain-behavior relationships that may underlie different psychological and psychiatric domains in autistic children, adolescents, and adults. The ultimate goal of this research is to improve our understanding of the development of different cognitive and behavioral skills in order to develop mechanistically driven interventions that will improve precision medicine for mental health. Biologically based diagnosis and treatment are extremely limited for most psychological and psychiatric conditions but also critically needed to increase early identification and improve treatment outcomes, especially for neurodevelopmental disorders in which early intervention is the most beneficial. My early career research has primarily focused on clinical neuroscience using neuroimaging (e.g., MRI & EEG) to examine the effects of different drugs and behavioral interventions on the brain, especially for developing biomarkers for improving treatment planning and monitoring biological changes in response to single dose and clinical trials.
My primary contributions to science thus far fall within these major categories: 1) identifying the neural correlates of individual differences in cognition and behavior, 2) developing new interventions and investigating the neurobiological substrates of response to treatment, 3) examining different factors that contribute to brain development, 4) summarizing and increasing accessibility to autism-related research, and 5) methods development for neuroimaging studies. My earliest research investigated the neurobiology of alexithymia, dyslexia, and stress using structural and functional magnetic resonance imaging to test theories of the mechanisms that contribute to differences in cognition and behavior. My subsequent dissertation research, in which I began to focus on neurodevelopmental disorders, examined the neural correlates of response to beta-blockers in autistic adults and also assessed the contribution of cerebellar circuits to the autism phenotype. During my postdoctoral training, I have developed further skills for working with children in multiple clinical research settings, especially for using advanced neuroimaging approaches to examine important brain-behavior relationships. This includes a recent K99/R00 from the National Institute of Child Health and Human Development (NCT04278898 & NCT05664789) that will assess the neurobiology of restricted and repetitive behaviors in autistic children and examine the efficacy and target engagement of a novel nutritional supplement and investigational drug, N-acetylcysteine (NAC), in the brain. You can find more information about our NAC studies at https://redcap.link/NACandAutism. -
Samantha Hemingway, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Samantha Hemingway is a licensed, fellowship-trained clinical psychologist and clinical assistant professor in the Anxiety and Depression Adult Psychological Treatment (ADAPT) Clinic, Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.
Dr. Hemingway specializes in the treatment of obsessive-compulsive disorder (OCD) and related disorders, as well as anxiety and mood disorders. She has experience providing treatment in various levels of care settings, ranging from outpatient and intensive outpatient to partial hospitalization. Her work emphasizes evidence-based, high-quality, and personalized mental health care.
Dr Hemingway has published her research in several peer-reviewed journals, including International Journal of Psychological Research and Reviews and Journal of American College Health. She has also shared her expertise nationally and internationally at meetings of the American Psychological Association (APA), the International Association for Cross-Cultural Psychology, and the Association for Psychological Science.
Dr. Hemingway is a member of the APA, Society of Clinical Psychology, and Society for Clinical Neuropsychology. -
Charlie Heriot-Maitland
Adjunct Lecturer, Psych/Public Mental Health & Population Sciences
BioDr Heriot-Maitland is a clinical psychologist, trainer, researcher, and author. He is an international expert in Compassion Focused Therapy (CFT), and specifically the application of CFT for voice-hearing, trauma, and for people with psychosis and complex needs. Dr Heriot-Maitland is an experienced CFT therapist himself, and for the last 10 years has been leading the international development, research, and training of CFT for psychosis. His clinical research in this area has been mainly carried out at King’s College London and University of Glasgow, supported by funding from the UK Medical Research Council.
Dr Heriot-Maitland has published extensively on the theory and application of CFT in academic journals, produced videos and training materials, and has co-authored a self-help book on CFT for voice-hearers (Routledge, 2022). He has also developed novel and innovative interventions, based on CFT, for applications in different sectors (e.g., healthcare, social care, and education). Since 2012, he has been co-director of a UK organisation, Balanced Minds, which specialises in providing CFT therapy and resources for the general public and CFT training and supervision for professionals. He has been delivering training sessions at Stanford since 2019, and has held an Adjunct Lecturer appointment with the university since 2022. -
Kimberly Hill
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Hill received her Ph.D. in Clinical Psychology from Ohio University. She completed her doctoral internship at the Veterans Affairs Palo Alto Health Care System and postdoctoral fellowship in the Psychiatry Department at the Stanford University School of Medicine where she currently serves as a Clinical Professor. Dr. Hill has published articles and made presentations related to psychology training, pain management, serious mental illness including Post Traumatic Stress Disorder, and sexual dysfunction.
Dr. Hill's time is divided across clinical, research, administrative, and teaching domains. Her current clinical interests are varied including anxiety, mood disorders, relationship difficulties, and post-traumatic stress disorder. The bulk of her time is committed to psychology training as the Director of Clinical Training for the PGSP-Stanford Psy.D. Consortium. On a national level, she currently serves as the Vice Chair of the Association of Psychology Postdoctoral and Internship Centers (APPIC). -
Rachel Hilton
Casual - Non-Exempt, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Current Role at StanfordResearch Nurse Practitioner- Precision Psychiatry for Williams PanLab, Department of Psychiatry and Behavioral Sciences- Stanford University
-
Kyle Hinman, M.D.
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsAutism, Bipolar Disorder
-
Melanie Hom
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Melanie Hom is a Clinical Associate Professor and attending psychologist in the Anxiety and Depression Adult Psychological Treatment (ADAPT) Clinic, Dialectical Behavior Therapy (DBT) Clinic, and Stanford Mental Health for Asians Research and Treatment (SMHART) Clinic. She utilizes evidence-based therapies, including acceptance and commitment therapy (ACT), cognitive behavioral therapy (CBT), and DBT. Dr. Hom also strives to provide culturally informed psychotherapy in her work with individuals, couples, and families. Her research interests include (1) enhancing help-seeking and treatment engagement among individuals at elevated suicide risk and (2) improving mental health care services for Asians and Asian Americans.
